Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib keynote-012 study

Rita Nanda*, Laura Q.M. Chow, E. Claire Dees, Raanan Berger, Shilpa Gupta, Ravit Geva, Lajos Pusztai, Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, Vassiliki Karantza, Laurence Buisseret

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1154 Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib keynote-012 study'. Together they form a unique fingerprint.

Medicine & Life Sciences